Liver cirrhosis is a chronic progressive liver disease. A non-invasive diagnostic technique for hepatic fibrosis combined with liver biochemistry, molecular biology, and immunology, imaging study, liver histopathological assessment, and traditional Chinese medicine (TCM) syndrome differentiation can accurately diagnose the cause, severity of disease, and determine the prognosis. In clinical practice of Western medicine, there are five-stages of cirrhosis classification, with periods 1 and 2 being compensated stage, and periods 3 to 5 being decompensated stage. Etiological treatment and anti-hepatic fibrosis treatment are the basic measures for different disease severity and complications. Comprehensive application of modern medical technology and traditional Chinese medicine differentiation therapy can improve the treatment effect and survival rate.
肝硬化为慢性进展性肝病，联合应用肝脏生物化学、分子生物学、免疫学及肝纤维化无创诊断技术、影像学、肝组织病理学评估，结合中医辨证分析，可精准诊断病因、疾病严重程度及判断预后。西医临床多采用五期分类法，1、2期为代偿期，3～5期为失代偿期。病因治疗及抗肝纤维化治疗为基本措施，针对不同病期及并发症的严重程度，综合应用现代医学技术及中医辨病辨证治疗，可改善治疗效果，提高生存率。.
Keywords: Integrated traditional Chinese and Western medicine; Liver cirrhosis; Treatment.